Following last week’s Israeli cancer breakthrough (see here), now Weizmann Institute researchers have found an antibody (against CD84) that prevents tumors building molecular bridges from suppressing the immune system. Lab tests were successful at treating triple-negative breast cancer. https://www.jns.org/israeli-antibody-treatment-targets-most-aggressive-breast-cancer/#: https://wis-wander.weizmann.ac.il/life-sciences/burning-cancer%E2%80%99s-bridges … Continue reading →

A three-year-old boy hospitalized in Jerusalem with a severe blood cancer got a new lease on life thanks to the selflessness of Matan Amir, a 21-year-old IDF soldier fighting in Gaza who was identified as a suitable bone marrow donor … Continue reading →

The Nobel Prize in medicine was awarded to Americans Victor Ambros and Gary Ruvkun for their discovery of microRNA. Both men were awarded Israel’s Wolf Prize in 2014. Ruvkun, who is Jewish, won the Dan David Prize, headquartered at Tel … Continue reading →

An international study led by Israel’s Ben-Gurion University scientists showed controlling blood sugar levels is a significant key mechanism linking diet to slower brain aging. The 300-participant study was one of the longest and largest brain MRI trials in the … Continue reading →

Hebrew University of Jerusalem’s Prof Haitham Amal (see here previously) is the only non-USA member of a new consortium focused on pioneering autism research. It has just been awarded a research grant of $17 million by the California Institute for … Continue reading →

Denmark’s Medicines Agency has approved Allocetra cell therapy from Israel’s Enlivex (see here previously) for Phase II clinical trials on patients with osteoarthritis in the knee. 40% of men and 47% of women develop knee osteoarthritis in their lifetimes. Allocetra … Continue reading →

Israel’s BeiGene has received Israeli Ministry of Health approval for its TEVIMBRA® to treat Esophageal Squamous Cell Carcinoma (ESCC) after chemotherapy.  It has also gone on sale in the USA. https://ir.beigene.com/news/beigene-receives-israeli-ministry-of-health-approval-for-tevimbra-for-the-treatment-of-oesophageal-squamous/dc2e4d21-42f4-4545-af69-ba4e09a40194/ https://ir.beigene.com/news/beigene-announces-availability-of-tevimbra-in-u-s/1d4b131f-7226-4196-bbac-dc310930b1ad/ https://www.beigene.com/